Let's Talk About This

Altering the human germline through genome editing needs further ethical discussion by the scientific community, the White House says.

"The Administration believes that altering the human germline for clinical purposes is a line that should not be crossed at this time," writes John Holdren, the director of the White House Office of Science and Technology Policy, in a blog post.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.